Valeant has reportedly poached a new CFO from the animal-health company Zoetis

The embattled drugmaker Valeant Pharmaceuticals is reportedly hiring a new chief executive officer from an animal-health company.

Valeant is expected to announce its hire of Paul Herendeen, who is currently CFO at Zoetis, on Monday, The Wall Street Journal’s Vipal Monga reports.

He will replace Robert Rosiello, who took over that role from Howard Schiller in July of last year.

Valeant hired a new general counsel and made changes to its executive committee earlier this month.

The mutual fund T. Rowe Price last week filed a lawsuit against Valeant, alleging that its practices surrounding the mail-order pharmacy were fraudulent.

Valeant is also under criminal investigation related to its relationship with Philidor.

Read the full story in The Wall Street Journal >

NOW WATCH: Warren Buffett’s sister needs your help giving away millions

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at